Loading company…
OBaris develops needle-free drug delivery products.
OBaris's OctoPatch is applied inside the cheek as an alternative to injections. It is intended for patients with conditions including type 2 diabetes and osteoporosis. Founded in 2022, the company is based in Schlieren, Switzerland. It raised CHF 0.15 million from Venture Kick in March 2024.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in